alexa
Reach Us +1-504-608-2390
Antitumor Virotherapy Based On Attenuated Measles Virus: Consequences On The Antitumor Immune Response | 19562
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Clinical & Cellular Immunology

Jean-Francois Fonteneau
ScientificTracks Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.017
Abstract
Antitumor viro therapy consists in the use of oncolytic viruses able to infect and kill tumor cells without or with limited infection of healthy cells. Antitumor viro therapy is also able to induce or reinforce the antitumor immune response. Our group studies the Schwarz attenuated strain of measles virus (MV) for its oncolytic properties against various cancers, notably pleural mesothelioma. MV enters cells by the CD46 molecule that is often over expressed by numerous types of tumor cells. Recently, we studied how MV or MV-infected tumor cells can influence the antitumor immune response by studying their effects on myeloid and plasmacytoid dendritic cells (mDC and pDC) that are specialized in T cell response induction. We found that MV-infected tumor cells induced maturation of both types of DC, whereas tumor cells killed by UV- irradiation were not able to induce maturation. Then, we found that this maturation was mainly due to danger signals released by infected tumor cells for the activation of mDC and to MV ssRNA for the activation of pDC via TLR7. pDC maturation was accompanied by a strong production of IFN-α. In addition, we observed that MV-infected and UV-irradiated tumor cells were efficiently phagocytosed by mDC and pDC. Interestingly, we observed cross-presentation of the tumor antigen, NYESO-1, to a specific CD8+ T-cell clone only when mDC and pDC were cocultured with MV-infected tumor cells. Altogether, our results showed that the use of MV as an oncolytic virus induces immunogenic tumor cell death, allowing cross-presentation of tumor antigens by mDC and pDC. This phenomenon suggests that MV based antitumor virotherapy may strengthen the anti-tumor immune response by recruitment of DC.
Biography
Jean-Francois Fonteneau received the PhD degree from Nantes University, France, in 1999. During his thesis training, he studied CD8+ T lymphocytes response against melanoma in the INSERM Laboratory of Pr Francine Jotereau, Nantes, France. He then joined Dr. Nina Bhardwaj?s group in Dr. Ralph Steinman Laboratory as a Postdoctoral Fellow at Rockefeller University, New York, USA, from 1999 to 2003, where he studied dendritic cells (DC) biology, notably cross-presentation of viral and tumor antigens and interactions between virus/myeloid DC/plasmacytoid DC. In 2003, he returned to Pr Francine Jotereau Laboratory, INSERM U892, Nantes to identify new melanoma epitopes recognized by patient?s CD8+ and CD4+ T cells. In 2009, he joined Dr. Marc Gregoire's Laboratory, INSERM U892, Nantes, to study attenuated measles virus as an oncolytic virus for antitumor virotherapy of pleural mesothelioma to induce immunogenic cell death of tumor cells
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version